Early Infectious Disease Consultations in Staphylococcus Aureus Bacteremia
Early Infectious Disease Consultation for Better Outcomes From Staphylococcus Aureus Bacteremia
研究概览
详细说明
Bacteremia is a serious manifestation of Staphylococcus aureus infection with an attributable mortality as high as 25% in MRSA bacteremia. More than a third of patients end up with complications such as endocarditis, osteomyelitis or pneumonia.
Overall the outcome of patients with respect to mortality or recurrence is better in patients who have an eradicable focus and have received an appropriate antibiotic dose and duration. Also complicated bacteremia is more common in patients with
- persistent bacteremia or fever
- prosthetic device
- new murmur
- skin findings of a systemic infection
Based on this evidence, an ID consultation could improve the outcomes of patients with SAB by
- Advising adequate antibiotic dosage and duration
- Sourcing out and counselling eradication of any focus of infection
研究类型
注册 (预期的)
阶段
- 不适用
联系人和位置
学习地点
-
-
-
Singapore、新加坡、11974
- 招聘中
- National University Hospital
-
接触:
- Paul A Tambyah, Dip ABIM
- 电话号码:(65)67724375
- 邮箱:mdcpat@nus.edu.sg
-
首席研究员:
- Paul A Tambyah, Dip ABIM
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- All inpatients at the National University Hospital with Staphylococcus aureus (both methicillin sensitive and methicillin resistant) bacteremia isolated within the defined time period
Exclusion Criteria:
- Patients who died or were discharged before the notification from the laboratory
- Neonates
- Polymicrobial bacteremia
学习计划
研究是如何设计的?
设计细节
- 主要用途:卫生服务研究
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
有源比较器:ID
Patients receiving an early Infectious disease consultation ( within first 48 hours of a positive blood culture)
|
Randomised trial to determine the utility of an early Infectious disease Consultation in Staphylococcus aureus bacteremic patients ( in the first 48 hours of a positive blood culture)
其他名称:
|
|
无干预:NO ID
Includes those patients who do not receive an Infectious disease consultation in the first 48 hours
|
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
死亡
大体时间:1年
|
1年
|
次要结果测量
结果测量 |
大体时间 |
|---|---|
|
recurrence
大体时间:2 year
|
2 year
|
|
duration of hospitalisation
大体时间:1 year
|
1 year
|
|
financial costs of hospitalisation
大体时间:1 year
|
1 year
|
合作者和调查者
调查人员
- 首席研究员:Paul A Tambyah, MD、National University, Singapore
研究记录日期
研究主要日期
学习开始
初级完成 (预期的)
研究完成 (预期的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (估计)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.